India's New Weapon Against Superbugs: Wockhardt's Zaynich Offers Hope in Global AMR Crisis

Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs

MicrobiotiX Secures Landmark KRW 20 Billion Series B Funding, Catalyzing Korea's First-Ever Bacteriophage Clinical Trial to Combat Superbugs